* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 19.Immunoprevention
Survey
Document related concepts
Adaptive immune system wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Gastroenteritis wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Infection control wikipedia , lookup
Molecular mimicry wikipedia , lookup
Globalization and disease wikipedia , lookup
Thiomersal controversy wikipedia , lookup
Vaccination policy wikipedia , lookup
Hepatitis B wikipedia , lookup
Herd immunity wikipedia , lookup
Meningococcal disease wikipedia , lookup
Whooping cough wikipedia , lookup
DNA vaccination wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
HIV vaccine wikipedia , lookup
Non-specific effect of vaccines wikipedia , lookup
Transcript
Immunoprevention Definition By using immunological agents to construct, improve or inhibit immune response, people can prevent some diseases. Artificial immunization (active and passive) Development of new vaccines Application of vaccines Active Immunization Administration of an antigen (usually as a modified infectious agent or toxin) Passive Immunization Administration of antibody, or antibody-contained serum for passive protection of the host Acquisitions of active and passive immunity Active Immunization Elicit protective immunity: Ab, cellular responses Elicit immunologic memory Methods: natural infection, vaccines Principles of active Immunization Basic features of vaccine Safe Effective Practical Types of vaccines 1.Attenuated organisms (Measles) 2.Inactivated organisms (Hepatitis A vaccine) 3.Toxoid (Diphtheria, Tetanus) Whole organisms Some conditions should not use active immunization 1. 2. 3. 4. 5. 6. 7. 8. 9. Fever Severe heart disease Acute transmitted infection Cancer Kidney disease TB infection Grave’s disease Diabetes Immunodeficiency disease Passive Immunization Transfer of preformed antibodies The protection is transient No memory response There are some conditions that warrant the use of passive immunization Deficiency of antibody synthesis Exposure or likely exposure to a disease that will cause complications Infection by pathogens whose effects may be ameliorated by antibody Weakness of passive immunization 1. Isotypic determinants of the foreign antibody (IgE production) 2. Formation of immune complex (IgG, IgM) 3. Anti-allotype responses Planned Immunization Childhood immunizations have already been a part of routine health care. Planned Immunization Schedule in China (1) Primary Immunization Age Type of vaccines Birth BCG vaccine, Hepatitis B virus vaccine (1 st) 1 month Hepatitis B virus vaccine (2 nd) 2 months Poliovirus vaccine ( 1st) 3 months Poliovirus vaccine ( 2nd), DTP (1st) 4 months Poliovirus vaccine (3rd), DTP (2nd) 5 months DTP (3rd) 6 months Hepatitis B virus vaccine (3rd), Meningococcal polysaccharide vaccine 8 months Measles virus vaccine 1 year Japanese encephalitis vaccine (1st and 2nd) Planned Immunization Schedule in China (2) “Booster” /reimmunization Age Type of vaccines 1.5 years DTP, Measles virus vaccine, poliovirus vaccine, Meningococcal polysaccharide vaccine 2 years Japanese encephalitis vaccine 3 years Japanese encephalitis vaccine 4 years Poliovirus vaccine 5 years DTP, Measles virus vaccine, BCG vaccine, Japanese encephalitis vaccine Development of new vaccines Subunit vaccines Conjugate vaccines Synthetic peptide vaccines Recombinant vector vaccines Gene-engineering vaccines DNA vaccines Transgenic plant vaccines Subunit vaccines The current vaccine for Streptococcus pneumoniae, which causes pneumococcal pneumonia, consists of 23 antigenically different capsular polysaccharides. The vaccine induces formation of opsonizing antibodies and is now on the list of vaccines recommended for all infants. The vaccine for Neisseria meningitidis, a common cause of bacterial meningitis, also consists of purified capsular polysaccharides. One limitation of polysaccharide vaccines is their inability to activate Th cells. Conjugated vaccines Involve Th cells directly in the response to a polysaccharide antigen conjugate the antigen to some sort of protein carrier. For example, the vaccine for Haemophilus influenzae type b (Hib), the major cause of bacterial meningitis in children less than 5 years of age, consists of type b capsular polysaccharide covalently linked to a protein carrier, tetanus toxoid. Synthetic peptide vaccines The use of synthetic peptides as vaccines has not progressed as originally projected. Peptides are not as immunogenic as proteins, and it is difficult to elicit both humoral and cellular immunity to them Multivalent Vaccines Recombinant vector vaccines Genes that encode major antigens of specially virulent pathogens can be introduced into attenuated viruses or bacteria. The attenuated organism serves as a vector, replicating within the host and expressing the gene product of the pathogen. Salmonella typhimurium Recombinant adenovirus for tumor Genetic engineering vaccines Theoretically, the gene encoding any immunogenic protein can be cloned and expressed in bacterial, yeast, or mammalian cells using recombinant DNA technology. This vaccine was developed by cloning the gene for the major surface antigen of hepatitis B virus (HBsAg) and expressing it in yeast cells. DNA vaccines Plasmid DNA encoding a protein antigen from a pathogen can serve as an effective vaccine inducing both humoral and cellmediated immunity. DNA vaccines induce humoral and cellular immunity DNA vaccines induce humoral and cellular immunity Transgenic plant vaccines Application of vaccines 1. Prevention of infectious disease 2. Prevention of tumor 3. Others (Prevention of conception, treatment of drug dependency) Review questions 1. What are the advantages and disadvantages of using attenuated organisms as vaccines? 2. A young girl who had never been immunized to tetanus stepped on a rusty nail and got a deep puncture wound. The doctor cleaned out the wound and gave the child an injection of tetanus antitoxin. a. Why was antitoxin given instead of a booster shot of tetanus toxoid? b. If the girl receives no further treatment and steps on a rusty nail again 3 years later, will she be immune to tetanus?